Jyong Biotech Ltd.
MENS
$55.24
$1.182.18%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
10/10/2025
-
MarketBeat
10/6/2025
-
MarketBeat
10/1/2025
-
MarketBeat
9/30/2025
-
MarketBeat
9/29/2025
-
Ticker Report
9/29/2025
-
MarketBeat
9/29/2025
-
GuruFocus
9/29/2025
-
Globe Newswire
9/24/2025
-
MarketBeat
9/22/2025
-
MarketBeat
9/20/2025
-
MarketBeat
9/19/2025
-
TipRanks Financial Blog
9/19/2025
-
TipRanks Financial Blog
9/19/2025
-
The Fly
9/19/2025
-
The Fly
9/18/2025
-
GuruFocus
9/18/2025
-
Globe Newswire
9/17/2025
-
MarketBeat
9/16/2025
-
GuruFocus
9/16/2025
-
GuruFocus
9/16/2025
-
The Fly
9/16/2025
-
Globe Newswire
9/14/2025
-
MarketBeat
9/13/2025
-
MarketBeat
9/12/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, April 23, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of October (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
886 2 2732 5205
Address
No. 95, Xintai 5th Road
23F-3 - Section 1
Xizhi District New Taipei City, 221
23F-3 - Section 1
Xizhi District New Taipei City, 221
Country
Year Founded
Business Description
Sector
--
Industry
--
Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union...
more